ARCHIVES

“Recalcitrant” Cancers? Committee Rewrite Of Pancreatic Bill Raises New Questions

This article is from The Cancer Letter archive.

Vol. 38 No. 34 | September 14, 2012

Download PDF Visit The Full Archive

Related Articles

Also in this 8-page issue: FISH assay predicts survival on Iressa, Univ. of Colorado Cancer Center study finds.

May 6, 2005

2015 Goal Not a Dream, But a Vision, Director Says

July 18, 2003

CCOPs ask NCI officials about one-year extensions.

May 20, 2005

UT-Houston Wins NIH Center Grant For Alternative Cancer Medicine Studies

November 3, 1995

NCI Advisors Approve New Grant Programs In Systems Genetics, Tumor Stem Cells.

November 23, 2007

Drugs and Targets: FDA approves Velcade in mantle cell lymphoma

October 17, 2014